- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: Substance Withdrawal Syndrome.
Displaying page 1 of 1.
EudraCT Number: 2006-005235-14 | Sponsor Protocol Number: P05042 | Start Date*: 2007-07-11 | |||||||||||
Sponsor Name:Integrated Therapeutics Group Inc | |||||||||||||
Full Title: A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users | |||||||||||||
Medical condition: Opioid dependence | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) GB (Completed) ES (Completed) CZ (Completed) PT (Completed) SI (Completed) DE (Completed) IE (Completed) IT (Completed) LT (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002185-60 | Sponsor Protocol Number: SUB9001 | Start Date*: 2009-07-09 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Mundipharma Medical Company, Basel | |||||||||||||||||||||||||||||||||||||||||||
Full Title: RANDOMISED, CONTROLLED CLINICAL STUDY REGARDING THE FEASIBILITY OF CONVERTING OPIATE DEPENDENTS FROM METHADONE SUBSTITUTES TO SLOW RELEASE MORPHINE SULPHATE (SEVRE-LONGĀ®) | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with an opioid or multiple substance dependence (including opioids), actually enrolled in a methadone maintenance therapy in one of the study centres (ICD classifications F11.22, F19.22). | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002708-26 | Sponsor Protocol Number: CRC341 | Start Date*: 2017-06-28 | ||||||||||||||||
Sponsor Name:University of Surrey | ||||||||||||||||||
Full Title: A randomised double blind placebo controlled pilot trial of oxytocin efficacy in treating detoxified opioid dependent individuals | ||||||||||||||||||
Medical condition: Opioid dependence. The study will be investigating the efficacy of Syntocinon (oxytocin) on treating the withdrawal symptoms and cravings that opioid (e.g. almost always heroin) dependent individua... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-005234-21 | Sponsor Protocol Number: P04843 | Start Date*: 2007-11-28 | |||||||||||
Sponsor Name:Schering-Plough Research Institute | |||||||||||||
Full Title: A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid-Dependent Subjects. | |||||||||||||
Medical condition: Opioid dependance | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) GB (Completed) SE (Completed) PT (Completed) DK (Completed) LT (Completed) SI (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023342-67 | Sponsor Protocol Number: C38072/3081 | Start Date*: 2011-07-20 | |||||||||||
Sponsor Name:Teva Branded Pharmaceutical Products R&D, Inc. | |||||||||||||
Full Title: A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) wit... | |||||||||||||
Medical condition: Treatment for patients with eosinophilic asthma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) SE (Completed) HU (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001088-28 | Sponsor Protocol Number: BRIO | Start Date*: 2016-01-14 | ||||||||||||||||
Sponsor Name:South London and Maudsley NHS Foundation Trust [...] | ||||||||||||||||||
Full Title: Feasibility, efficacy and acceptability of injected buprenorphine as treatment for opiate users who persist in injecting illicit heroin through opiate maintenance treatment | ||||||||||||||||||
Medical condition: Addiction to illicit heroin | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002924-17 | Sponsor Protocol Number: CLR_15_05 | Start Date*: 2015-11-12 |
Sponsor Name:Sun Pharma Global FZE | ||
Full Title: A Phase III, Randomized, Double-Blind, Double Dummy, Active Controlled, Multi-Center Study To Evaluate The Efficacy And Safety Of Intravenous Pegylated Liposomal Prednisolone Sodium Phosphate (Nano... | ||
Medical condition: Active Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-005969-13 | Sponsor Protocol Number: AXA1665-101 | Start Date*: 2021-08-11 | ||||||||||||||||
Sponsor Name:Axcella Health, Inc. | ||||||||||||||||||
Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AXA1665 in Subjects With Liver Cirrhosis and Prior Overt Hepatic Encephalopathy (EM... | ||||||||||||||||||
Medical condition: Overt Hepatic Encephalopathy in Subjects with Liver Cirrhosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) PL (Completed) HU (Prematurely Ended) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024614-66 | Sponsor Protocol Number: C38072/3082 | Start Date*: 2011-07-20 | |||||||||||
Sponsor Name:Teva Branded Pharmaceutical Products R&D, Inc | |||||||||||||
Full Title: A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the reduction of Clinical Asthma Exacerbations in Patients (12-75... | |||||||||||||
Medical condition: Treatment for patients with eosinophilic asthma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) SE (Completed) CZ (Completed) DK (Completed) HU (Completed) PL (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2022-003743-10 | Sponsor Protocol Number: BPL-003-201 | Start Date*: 2023-06-22 | |||||||||||
Sponsor Name:Beckley Psytech Ltd. | |||||||||||||
Full Title: A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, with Open Label Extension, in Patients with Treatment Resistant Depression | |||||||||||||
Medical condition: Treatment-Resistant Depression (TRD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) PL (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005951-19 | Sponsor Protocol Number: APL-D-003-20 | Start Date*: 2021-06-08 | |||||||||||
Sponsor Name:Pharma Mar, S.A. | |||||||||||||
Full Title: A Phase 3, Multicentre, Randomised, Controlled Trial to Determine the Efficacy and Safety of Two Dose Levels of Plitidepsin Versus Control in Adult Patients Requiring Hospitalisation for Management... | |||||||||||||
Medical condition: moderate COVID-19 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) BG (Prematurely Ended) GR (Prematurely Ended) PT (Prematurely Ended) ES (Prematurely Ended) RO (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.